Back to Archived Journals » Biosimilars » Volume 5
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Pharmacokinetic and pharmacodynamic properties of a new biosimilar filgrastim TPI G-CSF in comparison to the marketed reference filgrastim Neupogen®: a double-blind, single-dose, two-period crossover trial
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
18,525 | Dovepress* | 18,525+ | 1,190 | 19,715 | |
Totals | 18,525 | 1,190 | 19,715 | ||
*Since 3 November 2015 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on Google Scholar